These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Muscle Nerve; 1995 Feb; 18(2):137-53. PubMed ID: 7823972 [Abstract] [Full Text] [Related]
6. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, Yuki N. J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234 [Abstract] [Full Text] [Related]
7. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M. Proc Natl Acad Sci U S A; 2004 Aug 03; 101(31):11404-9. PubMed ID: 15277677 [Abstract] [Full Text] [Related]
8. The immunobiology of Guillain-Barré syndromes. Willison HJ. J Peripher Nerv Syst; 2005 Jun 03; 10(2):94-112. PubMed ID: 15958123 [Abstract] [Full Text] [Related]
9. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies]. Tagawa Y, Matsumoto Y, Yuki N. No To Shinkei; 1998 Sep 03; 50(9):849-53. PubMed ID: 9789308 [Abstract] [Full Text] [Related]
10. [Pathologic studies of Guillain-Barre syndrome (GBS) and 13 rabbits with experimental allergic neuritis]. Lin S. Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun 03; 23(3):162-4, 190. PubMed ID: 2390887 [Abstract] [Full Text] [Related]
11. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes]. Akiyama M, Koga M, Yoshino H, Hamaoka A, Noguchi Y, Hirata K, Yuki N. No To Shinkei; 2006 Jun 03; 58(6):477-81. PubMed ID: 16856515 [Abstract] [Full Text] [Related]
13. [Cellular aspect of neuroinflammation in Guillain-Barré syndrome: a key to a new therapeutic option?]. Créange A, Sharshar T, Raphaël JC, Gherardi R. Rev Neurol (Paris); 2002 Jan 03; 158(1):15-27. PubMed ID: 11938319 [Abstract] [Full Text] [Related]
14. Simultaneous Guillain-Barré syndrome and acute disseminated encephalomyelitis in the pediatric population. Bernard G, Riou E, Rosenblatt B, Dilenge ME, Poulin C. J Child Neurol; 2008 Jul 03; 23(7):752-7. PubMed ID: 18354151 [Abstract] [Full Text] [Related]
15. Co-morbid Guillain-Barré syndrome and acute disseminated encephalomyelitis. Mohammed RR, Jan MM. Neurosciences (Riyadh); 2013 Apr 03; 18(2):166-8. PubMed ID: 23545617 [Abstract] [Full Text] [Related]
16. [Guillain-Barre syndrome and its frontiers]. Azulay JP, Verschueren A, Attarian S, Pouget J. Rev Neurol (Paris); 2002 Dec 03; 158(12 Pt 2):S21-6. PubMed ID: 12690657 [Abstract] [Full Text] [Related]
17. Spinal nerve involvement in early Guillain-Barré syndrome: The Haymaker and Kernohan's legacy. Berciano J. J Neurol Sci; 2017 Nov 15; 382():1-9. PubMed ID: 29110997 [Abstract] [Full Text] [Related]
18. [Antiglycolipid antibody in inflammatory neuropathy]. Kusunoki S. Rinsho Shinkeigaku; 1995 Dec 15; 35(12):1370-2. PubMed ID: 8752399 [Abstract] [Full Text] [Related]
19. [No association between IgG anti-GTla antibody and bulbar palsy in Guillain-Barré and Fisher's syndromes]. Koga M, Yuki N, Hirata K. Rinsho Shinkeigaku; 1997 Nov 15; 37(11):1024-6. PubMed ID: 9503976 [Abstract] [Full Text] [Related]
20. [Antiganglioside antibodies: when, which and for what]. Gallardo E, Rojas-García R, Belvís R, Serrano-Munuera C, Ortiz E, Ortiz N, Grau J, Illa I. Neurologia; 2001 Nov 15; 16(7):293-7. PubMed ID: 11485721 [Abstract] [Full Text] [Related] Page: [Next] [New Search]